These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22443586)

  • 41. Isoform-selective inhibition of chrysin towards human cytochrome P450 1A2. Kinetics analysis, molecular docking, and molecular dynamics simulations.
    He L; He F; Bi H; Li J; Zeng S; Luo HB; Huang M
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6008-12. PubMed ID: 20832301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interindividual variation in relative CYP1A2/3A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic microsomes.
    Zhang WV; D'Esposito F; Edwards RJ; Ramzan I; Murray M
    Drug Metab Dispos; 2008 Dec; 36(12):2547-55. PubMed ID: 18809730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism-based inactivation of cytochrome P450 2B1 by 7-ethynylcoumarin: verification of apo-P450 adduction by electrospray ion trap mass spectrometry.
    Regal KA; Schrag ML; Kent UM; Wienkers LC; Hollenberg PF
    Chem Res Toxicol; 2000 Apr; 13(4):262-70. PubMed ID: 10775326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular cloning and functional analysis of cytochrome P450 1A2 from Japanese monkey liver: comparison with marmoset cytochrome P450 1A2.
    Narimatsu S; Oda M; Hichiya H; Isobe T; Asaoka K; Hanioka N; Yamano S; Shinoda S; Yamamoto S
    Chem Biol Interact; 2005 Feb; 152(1):1-12. PubMed ID: 15766918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
    Takemura H; Itoh T; Yamamoto K; Sakakibara H; Shimoi K
    Bioorg Med Chem; 2010 Sep; 18(17):6310-5. PubMed ID: 20696580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stereoselective epoxidation and hydration at the K-region of polycyclic aromatic hydrocarbons by cDNA-expressed cytochromes P450 1A1, 1A2, and epoxide hydrolase.
    Shou M; Gonzalez FJ; Gelboin HV
    Biochemistry; 1996 Dec; 35(49):15807-13. PubMed ID: 8961944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol.
    Badawi AF; Cavalieri EL; Rogan EG
    Metabolism; 2001 Sep; 50(9):1001-3. PubMed ID: 11555828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin.
    Takahashi E; Fujita K; Kamataki T; Arimoto-Kobayashi S; Okamoto K; Negishi T
    Mutat Res; 2002 Oct; 508(1-2):147-56. PubMed ID: 12379470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of structural modification on the inhibitory selectivity of rutaecarpine derivatives on human CYP1A1, CYP1A2, and CYP1B1.
    Don MJ; Lewis DF; Wang SY; Tsai MW; Ueng YF
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2535-8. PubMed ID: 12852960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of human CYP1 enzymes by a classical inhibitor α-naphthoflavone and a novel inhibitor N-(3, 5-dichlorophenyl)cyclopropanecarboxamide: An in vitro and in silico study.
    Juvonen RO; Jokinen EM; Javaid A; Lehtonen M; Raunio H; Pentikäinen OT
    Chem Biol Drug Des; 2020 May; 95(5):520-533. PubMed ID: 32060993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structures of human cytochrome P450 1A1 with bergamottin and erlotinib reveal active-site modifications for binding of diverse ligands.
    Bart AG; Scott EE
    J Biol Chem; 2018 Dec; 293(50):19201-19210. PubMed ID: 30254074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Theoretical quantitative structure-activity relationships of flavone ligands interacting with cytochrome P450 1A1 and 1A2 isozymes.
    Iori F; da Fonseca R; Ramos MJ; Menziani MC
    Bioorg Med Chem; 2005 Jul; 13(14):4366-74. PubMed ID: 15914008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2.
    Stiborová M; Frei E; Wiessler M; Schmeiser HH
    Chem Res Toxicol; 2001 Aug; 14(8):1128-37. PubMed ID: 11511187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes.
    Koehl W; Amin S; Staretz ME; Ueng YF; Yamazaki H; Tateishi T; Guengerich FP; Hecht SS
    Cancer Res; 1996 Jan; 56(2):316-24. PubMed ID: 8542586
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib.
    Uttamsingh V; Lu C; Miwa G; Gan LS
    Drug Metab Dispos; 2005 Nov; 33(11):1723-8. PubMed ID: 16103134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
    Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
    Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta.
    Czekaj P; Wiaderkiewicz A; Florek E; Wiaderkiewicz R
    Arch Toxicol; 2005 Jan; 79(1):13-24. PubMed ID: 15448981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1.
    Doostdar H; Burke MD; Mayer RT
    Toxicology; 2000 Apr; 144(1-3):31-8. PubMed ID: 10781868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioactivation of diesel exhaust particle extracts and their major nitrated polycyclic aromatic hydrocarbon components, 1-nitropyrene and dinitropyrenes, by human cytochromes P450 1A1, 1A2, and 1B1.
    Yamazaki H; Hatanaka N; Kizu R; Hayakawa K; Shimada N; Guengerich FP; Nakajima M; Yokoi T
    Mutat Res; 2000 Dec; 472(1-2):129-38. PubMed ID: 11113705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.